Inventor · disambiguated record
Ivan Franzoni
Also filed as: FRANZONI IVAN
4 granted patents·3 pending applications·10 citations·filing 2021–2025
70Inventor score
Top patents by PatentIndex Score
7 records- 0194US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 0293US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 0393US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 0482US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 0567US2025042897A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0659US2025304580A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 0756US2024309003A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useVIGIL NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ivan Franzoni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →